Bristol Myers Squibb Announces Update on Phase 3 CheckMate -548 Trial Evaluating Patients with Newly Diagnosed MGMT-Methylated Glioblastoma Multiforme Biotech Investing
Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of Patients with Severe and Critical COVID-19 Pharmaceutical Investing
Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts Pharmaceutical Investing
Gilead Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 Biotech Investing
Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine Pharmaceutical Investing
Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine Pharmaceutical Investing
Solarvest Launches World's First Organic DHA Omega-3 Fruit Gummy Drops for Children Biotech Investing
Algernon CEO and CSO to Discuss COVID-19 Study Interim Data Results Featured on Streetsmart Live! Webcast Biotech Investing
Bristol Myers Squibb to Announce Results for Fourth Quarter 2020 on February 4, 2021 Biotech Investing
